Biochips that sequentially capture and focus antigens for immunoaffinity MALDI-TOF MS: A new tool for biomarker verification

Proteomics

Volumn 10, Issue 21, 2010, Pages 3922-3927

  Brauer, Heather Ann ^a,b   Lampe, Paul D ^a,b   Yasui, Yutaka Y ^c   Hamajima, Nobuyuki ^d,f   Stolowitz, Mark L ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e Stratos Biosytems LLC   (United States)

^f NAGOYA UNIVERSITY   (Japan)

Author keywords

Antibody immobilization; Biochip; Biomarker; Mass spectrometry; Technology

Indexed keywords

BIOLOGICAL MARKER; DISULFIDE; PREALBUMIN;

ADULT; AGED; ANTIBODY AFFINITY; ARTICLE; BIOCHIP; CONTROLLED STUDY; ELECTROCHEMISTRY; FEMALE; HUMAN; HYDROPHILICITY; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN PURIFICATION; SENSITIVITY ANALYSIS; SURFACE PROPERTY;

ACETONITRILES; ANTIGENS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; DISULFIDES; FEMALE; HUMANS; IMMUNOASSAY; PREALBUMIN; PROTEIN ARRAY ANALYSIS; PROTEIN ISOFORMS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 78049399511     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000219     Document Type: Article

References (25)

1. Rifai, N., Gillette, M. A., Carr, S. A., Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24, 971-983.
2. Pang, S., Smith, J., Onley, D., Reeve, J. et al., A comparability study of the emerging protein array platforms with established ELISA procedures. J. Immunol. Methods 2005, 302, 1-12.
3. Alexe, G., Alexe, S., Liotta, L. A., Petricoin, E. et al., Ovarian cancer detection by logical analysis of proteomic data. Proteomics 2004, 4, 766-783.
4. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
5. Ye, B., Cramer, D. W., Skates, S. J., Gygi, S. P. et al., Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin. Cancer Res. 2003, 9, 2904-2911.
6. Adam, B. L., Qu, Y., Davis, J. W., Ward, M. D. et al., Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 2002, 62, 3609-3614.
7. Banez, L. L., Prasanna, P., Sun, L., Ali, A. et al., Diagnostic potential of serum proteomic patterns in prostate cancer. J. Urol. 2003, 170, 442-446.
8. Petricoin, E. F., 3rd, Ornstein, D. K., Paweletz, C. P., Ardekani, A. et al., Serum proteomic patterns for detection of prostate cancer. J. Natl. Cancer Inst. 2002, 94, 1576-1578.
9. Rosty, C., Christa, L., Kuzdzal, S., Baldwin, W. M. et al., Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 2002, 62, 1868-1875.
10. Valerio, A., Basso, D., Mazza, S., Baldo, G. et al., Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern. Rapid Commun. Mass Spectrom. 2001, 15, 2420-2425.
11. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., Chan, D. W., Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 2002, 48, 1296-1304.
12. Ferrari, L., Seraglia, R., Rossi, C. R., Bertazzo, A. et al., Protein profiles in sera of patients with malignant cutaneous melanoma. Rapid Commun. Mass Spectrom. 2000, 14, 1149-1154.
13. Gurard-Levin, Z. A., Mrksich, M., The activity of HDAC8 depends on local and distal sequences of its peptide substrates. Biochemistry 2008, 47, 6242-6250.
14. Neubert, H., Jacoby, E. S., Bansal, S. S., Iles, R. K. et al., Enhanced affinity capture MALDI-TOF MS: orientation of an immunoglobulin G using recombinant protein G. Anal. Chem. 2002, 74, 3677-3683.
15. Patrie, S. M., Mrksich, M., Self-assembled monolayers for MALDI-TOF mass spectrometry for immunoassays of human protein antigens. Anal. Chem. 2007, 79, 5878-5887.
16. Yeo, W. S., Mrksich, M., Electroactive self-assembled monolayers that permit orthogonal control over the adhesion of cells to patterned substrates. Langmuir 2006, 22, 10816-10820.
17. Yeo, W. S., Yousaf, M. N., Mrksich, M., Dynamic interfaces between cells and surfaces: electroactive substrates that sequentially release and attach cells. J. Am. Chem. Soc. 2003, 125, 14994-14995.
18. Yousaf, M. N., Houseman, B. T., Mrksich, M., Using electroactive substrates to pattern the attachment of two different cell populations. Proc. Natl. Acad. Sci. USA 2001, 98, 5992-5996.
19. Mrksich, M. a. H., C., United States Patent Application 2002.
20. Stolowitz, M. L., United States Patent Application 2009.
21. Nelson, R. W., Krone, J. R., Bieber, A. L., Williams, P., Mass spectrometric immunoassay. Anal. Chem. 1995, 67, 1153-1158.
22. Schuerenberg, M., Luebbert, C., Eickhoff, H., Kalkum, M. et al., Prestructured MALDI-MS sample supports. Anal. Chem. 2000, 72, 3436-3442.
23. Zhang, Z., Bast, R. C., Jr, Yu, Y., Li, J. et al., Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004, 64, 5882-5890.
24. de Boer, D., Erps, M. M., Wodzig, W. K., van Dieijen-Visser, M. P., Inadequate attempts to measure the microheterogeneity of transthyretin by low-resolution mass spectrometry. Clin. Chem. 2005, 51, 1299-1300; author reply 1300; discussion 1300-1291.
25. Zhang, X., Scalf, M., Berggren, T. W., Westphall, M. S., Smith, L. M., Identification of mammalian cell lines using MALDI-TOF and LC-ESI-MS/MS mass spectrometry. J. Am. Soc. Mass Spectrom. 2006, 17, 490-499.